Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Welgus Howard G.
Over the trailing 90 days, Welgus Howard G. (Director at Arcutis Biotherapeutics, Inc.) traded $309K of stock (net selling $179K) in ARQT, per 17 SEC Form 4 transactions.
- Role
- Director
- Companies
- ARQT
- Window
- Trailing 90 days · 17 transactions · CIK 1801050
- Net activity
- −$179K ($65K bought · $244K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 17 | $65K | $244K | −$179K |
Transactions (17)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-15 | ARQT | Sell | 822 | $0 | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Sell | 1.0K | $0 | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Buy | 822 | $5K | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Buy | 2.3K | $19K | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Sell | 2.3K | $0 | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Buy | 1.0K | $8K | Exercise or conversion of derivative security |
| 2026-07-15 | ARQT | Sell | 4.7K | $127K | Open market or private sale |
| 2026-06-17 | ARQT | Sell | 635 | $16K | Open market or private sale |
| 2026-06-15 | ARQT | Buy | 822 | $5K | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Buy | 2.3K | $19K | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Sell | 822 | $0 | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Sell | 1.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Sell | 2.3K | $0 | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Buy | 1.0K | $8K | Exercise or conversion of derivative security |
| 2026-06-15 | ARQT | Sell | 4.1K | $100K | Open market or private sale |
| 2026-06-05 | ARQT | Buy | 5.8K | $0 | Grant, award or other acquisition |
| 2026-06-05 | ARQT | Buy | 16.7K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Welgus's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.